Joseph Field, a San Francisco-based cosmetic dentist, told Drugwatch
Originally developed to treat type 2 diabetes and later approved for conditions like obesity and sleep apnea, these medications are now being touted by influencers and researchers alike for their potential as longevity drugs. Notably, a growing cohort of health professionals has been examining the potential impact of GLP-1s on longevity markers, such as cholesterol and glucose levels, which can shed light on overall health
Blood sugar levels rise more steadily as a result of this rather than experiencing the typical diabetes-related spikes
The two primary endpoints were the Kansas City Cardiomyopathy Questionnaire clinical summary score (KCCQ-CSS, which ranges from 0 to 100) and the Kansas City Cardiomyopathy Questionnaire Clinical Summary Score (KCCQ-CSS)
Highlights emerging opportunities for precision medicine by integrating cardiovascular and endocrine research
Statements Author contributions GL wrote the manuscript